Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Wed Apr 02 13:40:10 GMT 2025
by
admin
on
Wed Apr 02 13:40:10 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials State | LIVE GENETICALLY MODIFIED |
| Source Materials Parent | |
| Part | blood |
| Fraction Name | t cells |
| Record UNII |
NP6CFH3G8H
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
689519
Created by
admin on Wed Apr 02 13:40:10 GMT 2025 , Edited by admin on Wed Apr 02 13:40:10 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C160780
Created by
admin on Wed Apr 02 13:40:10 GMT 2025 , Edited by admin on Wed Apr 02 13:40:10 GMT 2025
|
PRIMARY | |||
|
NP6CFH3G8H
Created by
admin on Wed Apr 02 13:40:10 GMT 2025 , Edited by admin on Wed Apr 02 13:40:10 GMT 2025
|
PRIMARY | |||
|
JK-123
Created by
admin on Wed Apr 02 13:40:10 GMT 2025 , Edited by admin on Wed Apr 02 13:40:10 GMT 2025
|
PRIMARY | |||
|
300000028851
Created by
admin on Wed Apr 02 13:40:10 GMT 2025 , Edited by admin on Wed Apr 02 13:40:10 GMT 2025
|
PRIMARY | |||
|
11437
Created by
admin on Wed Apr 02 13:40:10 GMT 2025 , Edited by admin on Wed Apr 02 13:40:10 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET->CYTOTOXIC T-CELL |
Mesothelin is overexpressed in multiple cancers, including more than 90% of mesotheliomas and pancreatic adenocarcinomas, approximately 70% of ovarian cancers, and 50% of lung adenocarcinomas, among others
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| LENTIVIRAL TRANSFECTION | TRANSFECTION | GAVOCABTAGENE AUTOLEUCEL LENTIVIRAL VECTOR | 99PW2Y4WZ2 |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| VECTOR EXPRESSED PROTEIN | GAVOCABTAGENE AUTOLEUCEL CHIMERIC ANTIGEN RECEPTOR PREPROTEIN | B5KGT2Q7FN | ||||
| INSERTED GENE EXPRESSION VECTOR | UNSPECIFIED SUBSTANCE |
ddd0c12f
(not in database)
|
||||
| VECTOR EXPRESSED PROTEIN | GAVOCABTAGENE AUTOLEUCEL CHIMERIC ANTIGEN RECEPTOR | 7NH8H58KJG |